Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 130, pseudogene (RNU1-130P)
- Target
- RNU1-130P
- Molecular classification
- Pseudogene, Small nuclear RNA (snRNA, non-coding RNA, variant), Other
01
Overview
RNA, U1 small nuclear 130, pseudogene (RNU1-130P) is a human genetic locus annotated as a pseudogene due to disruptions in its sequence that prevent it from encoding a canonical functional snRNA. While the main U1 snRNA is essential for pre-mRNA splicing and transcriptome integrity, pseudogenes like RNU1-130P are generally considered nonfunctional. Recent studies indicate that some U1 snRNA pseudogenes can be actively transcribed and may produce variant snRNAs with putative regulatory roles in gene expression; however, no specific biological function has been established for RNU1-130P, and it is not a recognized therapeutic target. Its classification as a pseudogene means it does not encode a protein and is not directly targeted by existing drugs. The “incorrectness” of this target refers to its status as a non-protein, non-coding pseudogene, not its nomenclature, and the lack of evidence supporting any druggable function.
- Other names
- RNU1-130PRNA, U1 small nuclear 130, pseudogene
02
Mechanism of action
None. No drugs target this pseudogene, and its function does not allow for classical mechanism-based pharmacology.
03
Biological functions
No established protein-coding function; classically considered nonfunctionalRecent evidence suggests that some U1 snRNA pseudogenes (including similar loci) may be transcribed to produce variant snRNAs that have regulatory effects on gene expression, specifically mRNA 3′ end processing. However, a functional role has not been experimentally proven for RNU1-130P itself.Other
04
Disease associations
None definitively established for RNU1-130P.Related pseudogene transcripts elsewhere have been implicated as regulatory RNAs, sometimes acting as miRNA decoys or modulators of parental gene expression in cancer and other diseases, but no such role is known for RNU1-130P.
Beyond the preview
Go deeper on RNA, U1 small nuclear 130, pseudogene (RNU1-130P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U1 small nuclear 130, pseudogene (RNU1-130P).